Research Blog

How Quickly Should You See Results for KLOW and...

The GLOW and KLOW Blends contain compounds that act on genuinely different timescales — angiogenesis within days, collagen remodeling over weeks, structural tensile strength over months. This guide breaks down...

How Quickly Should You See Results for GLP II (...

Different GLP II (T) and GLP III (R) research endpoints emerge on genuinely different timelines — glycemic effects within days, body weight change over weeks, visceral fat reduction over months....

GLP Receptor Agonists and Gambling Behavior: Be...

Gambling disorder is the prototypical behavioral (non-substance) addiction, and its neurobiology overlaps substantially with the mesolimbic dopamine circuitry that GLP receptor agonists like GLP II (T) and GLP III (R)...

GLP Receptor Agonists and Anhedonia: What the R...

If GLP receptor agonists dampen dopamine release in the mesolimbic reward pathway to reduce food-seeking behavior, does that same mechanism blunt reward response more broadly — potentially producing anhedonia-like effects?...

BPC-157 and TB-500 in Companion Animal Research

TB-500's origin traces directly back to equine veterinary research, and its combination with BPC-157 in Proto Peptide's Wolverine Stack addresses tissue repair questions central to companion and working animal musculoskeletal...

Coming Off GLPs: The Physiology of Discontinuation

Tapering protocols tell researchers how to stop GLP II (T) or GLP III (R) dosing — but understanding what's actually happening at the receptor and systems level during discontinuation is...